Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial

Clicks: 465
ID: 120228
2010
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
PATH (GAVI Alliance grant) and Merck.
Reference Key
ge2010lancetefficacy Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Armah GE;Sow SO;Breiman RF;Dallas MJ;Tapia MD;Feikin DR;Binka FN;Steele AD;Laserson KF;Ansah NA;Levine MM;Lewis K;Coia ML;Attah-Poku M;Ojwando J;Rivers SB;Victor JC;Nyambane G;Hodgson A;Schödel F;Ciarlet M;Neuzil KM;;
Journal Lancet (London, England)
Year 2010
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/20692030
Keywords
Administration National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine research support non-u.s. gov't Infant developing countries* Randomized Controlled Trial Antibodies Double-Blind Method Multicenter Study severity of illness index viral / blood gastroenteritis / virology rotavirus infections / prevention & control* vaccines attenuated / administration & dosage attenuated / immunology gastroenteritis / prevention & control* rotavirus / immunology rotavirus vaccines / administration & dosage* immunization schedule africa south of the sahara oral rotavirus infections / immunology immunoglobulin a / blood kathleen m neuzil pmid:20692030 doi:10.1016/s0140-6736(10)60889-6 george e armah samba o sow rotavirus vaccines / immunology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.